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the impacts of intrauterine 
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Ahmad fuad4, Mohd Hafiz Dzarfan othman3*, Rosfaiizah Siran4, Noor Shafina Mohd Nor4,5, 
narimah Abdul Hamid Hasani4 & Siti Hamimah Sheikh Abdul Kadir1,4,5*
this study aimed to examine the impact of BpA exposure on pregnancy and foetuses on cardiac 
tissues and the expression of cardiac microRnAs (miRnAs) related to heart development and diseases. 
Pregnancy is known to be the “critical windows” in determining the offspring physical and cells 
development in their life after birth. The increment of the risk of cardiovascular disease (CVD) in a later 
stage of life has been reported by few studies demonstrated from prenatal exposure of BpA. BpA has 
been shown to alter miRNAs expression profiles for organ development, regeneration and metabolic 
functions. These alterations have been associated with the risk of CVDs. However, the associations 
between pregnancy outcomes and miRnAs expression in cardiac of mother- and foetuses-exposed to 
BPA are still not entirely explored. In BPA-exposed pregnant rat groups, a significant weight gained 
was observed in comparison to control (p < 0.05). Interestingly, significant changes in systolic and 
diastolic blood pressure between the first and third trimester of BPA-exposed pregnant rats were also 
observed (p < 0.05). In BPA-exposed pregnant rats, miR-499-5p was significantly altered in the heart 
(p < 0.01). Meanwhile, altered miR-17-5p, -208-3p, and -210-3p expressions were observed in all heart 
of the foetuses from BpA-exposed pregnant rats (p < 0.05). In H&E staining, BPA-exposed foetal hearts 
showed a sign of fibrosis while BPA-exposed pregnant rats showed muscle remnant. Masson trichrome 
staining further confirmed the presence of fibrosis observed in BPA-exposed foetal heart and reduced 
expression of cardiac troponin I (cTnI) was also observed in BPA-exposed foetal heart. In summary, 
altered cardiac miRnAs with histological changes were observed in both mother- and foetus-exposed 
BPA These findings put forward the importance of future work to further understand how prenatal BPA 
exposure affect foetuses in their later stage of life.
Altered foetal development “programming” may predispose certain individuals to the risk of chronic disease 
development later in their life. This was suggested by Barker and co-worker who presented the first finding on 
the increased risk of cardiovascular disease (CVD) in children of malnourished mothers1. Barker then further 
extended his theory and linked the CVD development and insulin resistance to the environment of the pla-
centa. His findings have attracted another study to report on the insufficiency of uteroplacental of malnutrition 
mothers increases the risk of the offspring to type 2 diabetes2. Another study demonstrated that miR-208, a 
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cardiac-specific miRNA, plays a role in the development of cardiac hypertrophy and fibrosis in response to stress3. 
Moreover, miR-133a was also found to be upregulated in the plasma of CVD patients4. Remarkably, these findings 
have led the scientist to associate miRNAs expression with the risk of heart disease development later in life.
Another study has demonstrated the importance of miR-1 and miR-133a in foetal heart development as both 
miRNAs are expressed in heart disease subjects and are required during organogenesis5. The study also reported 
the role of miR-208 in regulating myosin heavy chain (MHC) switching. The disruption of this gene may result in 
the activation of the fast-skeletal muscle gene program within the heart. Interestingly, miR-21 expression is typi-
cally altered following cardiac stresses and is detectable in almost every tissue throughout the body6. Apart from 
that, miR-499 was found to be elevated in the experimental animal models of infarction and human patients. This 
shows the potential usage of miR-499 as a biomarker for infarction7.
Bisphenol A (BPA) is ubiquitously used in the industrial sectors, hence humans are exposed to the compound 
repetitively8–10. Although there are BPA-free products, however, the compound is still widely found in many con-
sumer products. The contaminants are able to leach from those consumer products into the environment such 
as into water11, food12 and air13. Studies showed a significant level of urinary BPA were detected in BPA-related 
industrial workers and children12,14,15. In addition, BPA has also been detected in human serum with a concen-
tration up to 4.4 ng/ml16 and 11.2 ng/ml. However, concentration as high as 11.2 ng/ml has been reported to be 
harmful for embryo development17. Furthermore, epidemiological studies have reported the association of BPA 
exposure with the development of metabolic diseases, especially CVD18–22. They demonstrated the association of 
higher urinary BPA levels with an increased risk of coronary artery disease (CAD), hypertension, and myocardial 
infarction.
Although BPA is rapidly bio-transformed in the adults, previous studies have shown that during pregnancy, 
BPA could reach the foetus via placenta23, thus, potentially could affect the development of the foetal organs 
including brain24, heart18, liver25, lungs26 and ovary27. In relation to Barker’s hypothesis, recent evidence showed 
that exposure of BPA in the intrauterine environment in mice has altered glucose homeostasis and served as the 
risk factor for CVD and diabetes development in the offspring28. BPA exposure also alters miRNA expression in 
the female reproductive system29, liver30, heart31, placenta32 and others. miR-146a was found to be overexpressed 
in the placental cells leading to slower proliferation, thus, increasing the potential of DNA damage. Moreover, 
miR-192 has been reported to be downregulated in hepatic steatosis that triggers non-alcoholic liver disease30. 
Another interesting finding was conducted by Bhaskaran et al. who found the important role of miR-127 in the 
foetal lung development33.
On the basis of the above discoveries, we hypothesised that BPA exposure during intrauterine environment 
could alter the expression of miRNAs, thus increasing the possibility of CVD development in the offspring. This 
study was conducted to explore the effects of intrauterine BPA exposure to foetuses cardiac tissues and miRNAs 
that is important for cardiac development.
Main Text
Materials and methods. Chemicals. Tween-80 and BPA were purchased from Sigma Aldrich. In this 
study, Tween-80 was used as vehicle control for treatment (with 0.4% of Tween-80 in total solution). BPA was 
dissolved in Tween-80 (with the same volume) and prepared to 20 ppm concentrations. For liver histology stand-
ard protocol, paraformaldehyde (PFA) and phosphate buffer solution (PBS) were used and were purchased from 
Sigma Aldrich and Thermo Scientific, respectively.
Animals experimentation. Adult female rats aged six to eight weeks (Sprague Dawley) (weighing between 200–
250 g, n = 5) were housed individually and allowed free access for food and drinks. Females were mated with 
males rat in ratio 1:1 in different cages. The vagina smears were collected the next morning to confirm positive 
mating34. The pregnant rats were grouped into three categories namely drinking water containing vehicles (0.4% 
Tween-8035), water containing 5 ppm BPA and 20 ppm BPA (0.05 mg/ml and 0.2 mg/ml, respectively). Glass water 
bottles were used to avoid potential contamination from sources other than administration. The water intake 
was noted with an estimation of consumption approximately 25 mL or more per day. The treatment began on 
pregnancy day 2 (PD2) until pregnancy day 21 (PD21). The treatment began at PD2 to observe any significant 
effect on organogenesis36. This study was conducted in accordance with relevant guidelines and regulations and is 
approved by Universiti Teknologi MARA (UiTM) Committee of Animal Research and Ethics (Approval Number 
UiTM CARE: 222/7/2017 (8/12/2017)).
Throughout the treatment period, the weight of the pregnant rats was taken four times (on PD2, PD7, PD14 
and PD21) whereas blood pressure (BP) was recorded twice during early (PD2) and end (PD18) of the pregnancy. 
BP readings were taken twice to minimise stress factor in the treated rats as it may contribute to number of fac-
tors such as miscarriage. Apart from that, lighting and temperature of the animal room were also monitored and 
controlled. Food intake was measured four times throughout the treatment period in which each pregnant rat was 
supplied with approximately 230 g of normal diet pellet.
Non-invasive BP measurement on the pregnant rats were conducted using volume pressure recording (VPR) 
sensor technology according to the methodology described by Wang et al.37. The rats were placed in a strainer 
with the nose protruded through the front of the nose cone to allow comfortable breathing while the tail was fully 
extended and exited through the rear hatch opening of the holder. The blood flow and blood volume in the tail 
were measured by VPR system and generated BP readings simultaneously.
Caesarean section was performed on PD21 according to the previous protocol38. Each litter of rats were 
weighed, and the size was measured. The number of foetuses for each rat was recorded (n = 8–12 pups/rat). 
Both pregnant and foetuses heart were isolated, placed in RNAlater buffer (QIAGEN, Dusseldorf, Germany) and 
stored in 4 °C. The samples were then stored at −80 °C on the following day. The livers were collected from both 
the mothers and the foetuses for histology and examination (H&E).
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Liver histology and examination. Lobes of the mothers and foetal liver were fixed in 4% PFA in 0.1 M PBS, dehy-
drated, and embedded in paraffin. The livers were sectioned with 5 µm sections and transferred to microscope 
slides (Fisher Scientific, Whitby, ON). Sections were stained using the standard H&E protocol for histological 
analyses as described in a previous study39.
Heart histology and examination. Mothers heart were cut longitudinally while the total heart of the foetuses was 
used and fixed in formalin, dehydrated and embedded in paraffin. The hearts were sectioned with 5 µm sections 
and transferred to microscope slides (Fisher Scientific, Whitby, ON). Sections were stained using H&E protocol 
for histological analyses as described in a previous study39.
Sections were also stained for Masson Trichrome (MT) and immunofluorescence staining. For Masson 
Trichrome, the 5 µm sections of fetal hearts were deparaffined and stained according to the Masson Trichrome kit 
(Bio-Optica, Milano) prior to view.
Immunofluorescence staining was done by blocking the sections of fetal heart for 30 min with 1% horse serum 
in PBS, then incubated at room temperature for 3 hrs with primary antibody of troponin (1:400). Sections were 
washed thrice with PBS for 5 min and secondary antibody incubation was carried out using 1:500 fluorescein 
isothiocyanate (FITC). Subsequently they were washed thrice with PBS in 5 min. Tissues were counterstain with 
DAPI for 1 min, washed as previous. Tissues then were mounted with prolong gold antifade reagent and cover 
slipped prior to view under fluorescence microscope (Olympus, New York) and confocal microscope (Leica, 
UK)40.
miRNA extraction. In brief, the isolated samples were removed from RNAlater buffer (QIAGEN, Dusseldorf, 
Germany) and homogenised using a mortar and pestle41. miRNA was extracted from the heart samples using 
miRNeasy mini kit (QIAGEN, Dusseldorf, Germany). Approximately, three to four foetal hearts from each 
group or 40 mg of homogenised tissue was used for extraction. Extracted RNA was quantified using a Nanodrop 
spectrophotometer and aliquoted into single-use aliquots and stored at −80 °C. Total RNA was extracted from 
∼40 mg of heart tissue using the AllPrep miRNA Universal Kit following the manufacturer’s instructions.
miRNA polymerase chain reaction array (miRNA-PCR). Total RNA of 250 ng from tissue was used for cDNA 
synthesis using miScript RT II cDNA Synthesis Kit (QIAGEN, Dusseldorf, Germany) as per manufacturer’s pro-
tocols. miRNAs abundance was measured by miRNA PCR array using Applied Biosystems Fast Advanced Master 
Mix (QIAGEN, Dusseldorf, Germany). PCR was performed and the target genes were normalised to three cho-
sen reference genes. SNORD68, SNORD96A and RNU6–6P were employed as the reference genes to analyse 
miRNAs expression in the rat cardiac tissues42–44. The ratio between the target gene and the geometric mean of 
the reference genes were calculated to achieve mean normalised expression (MNE) of the target genes in each 
sample. For analyses, Ct values > 35 cycles were excluded from the analyses if duplicates had a standard deviation 
greater than 1 cycle. Final probe concentrations were maintained as suggested by the manufacturer in a 20 μl 
reaction. Sample concentrations were 1:10 dilution of the stock pre-amplification generated product as per the 
manufacturer’s protocol. Covariation (CV) of the reference genes was determined from Biorad CFX Manager 
3.1 that generate the stability values. CV value is an indicator of variation in a group, the less CV value showed 
low variation among the groups. From the data, the CV values of both reference genes of rat and foetus cardiac 
tissues were below 0.5, which indicates the stability of these genes is accurate and reasonable. miRNA PCR data 
was analysed using 2-ΔΔCT method.
The list of targeted miRNAs and their ID number were as tabulated in Table 1.
Statistical analysis. Non-parametric analysis was carried out using SPSS version 20 (SPSS, Inc.). Kruskal Wallis 
test was used where appropriate to compare control against BPA-exposed values with alpha set at p ≤ 0.05. Data 
are shown as mean ± SEM in miRNA expression while other data are shown as mean ± SD.
Results. BPA has no effect on the mothers and foetuses liver. Standard histology of the liver was performed to 
determine the effect of prenatal BPA exposure to structural liver maturation of foetus from PD2 to PD18. Upon 
miRNA ID number NCBI Accession ID Role of miRNA
rno-miR-15b-3p MS00026831 MIMAT0017093 Newborn heart development
rno-miR-21-5p MS00013216 MIMAT0000790 Disease biomarker and cardiac development
rno-miR-17-5p MS00013118 MIMAT0000786 Disease biomarker
rno-miR-133a-3p MS00033208 MIMAT0000839 Organogenesis, heart failure
rno-miR-208a-3p MS00033292 MIMAT0000880 Cardiac specific miRNA
rno-miR-499-5p MS00001169 MIMAT0003381 Myocardial infarction
rno-miR−210-3p MS00000644 MIMAT0000881 Hypoxia and heart disease
rno-miR-30a-5p MS00013363 MIMAT0000808 Cardiac muscle injury
SNORD68 MS00033712 NR_002450 Reference gene
SNORD96A MS00033733 NR_002592 Reference gene
RNU6-6P MS00033740 NR_002752 Reference gene
Table 1. Targeted miRNA and their manufactured ID number accession.
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observation, we found that there were no visible differences in the structure between control and BPA-exposed in 
both pregnant and foetal liver (Fig. 1).
The H&E-stained liver sections of the control and BPA-exposed rats revealed normal liver histology, dis-
playing a normal cell size, with a prominent cell nucleus, uniform cytoplasm, and radially aligned sinusoid and 
central vein. The similar structure pattern in the control and BPA-exposed foetus liver indicated that prenatal BPA 
exposure from PD2 to PD18 has no toxicity effect on the liver.
Exposure of BPA affects the histology of BPA-exposed pregnant rats and foetal heart. Histology of the mother’s and 
foetus heart was performed to compare the morphology of the muscle cells in control and BPA-exposed subjects 
(Fig. 2). The H&E heart sections showed a sign of fibrosis in the BPA-exposed foetus heart. Meanwhile, in the 
mothers, the heart of the BPA-exposed pregnant rats showed muscle remnants.
BPA exposure during pregnancy affects the mothers’ weight gained and blood pressure. In the pregnant rat, sys-
tolic blood pressures (SBP) and diastolic blood pressure (DBP) were measured at PD2 and PD18 (Fig. 3A). The 
difference in the SBP and DBP were found to be significant within the BPA-exposed groups (p < 0.05). The results 
indicated that both SBP and DBP significantly increased during pregnancy in both groups of BPA-exposed rats 
as compared to the control rats (p < 0.05). When the BPA-exposed groups are compared with the control group, 
the SBP (in the third trimester) was raised up from 125 ± 9.505 mmHg in control rats to 151 ± 4.50 mmHg and 
137 ± 10.46 mmHg in the 20 and 5 ppm BPA-exposed rats, respectively (p = 0.009). DBP progressively increased 
significantly during third trimester in the BPA-exposed groups from 92 ± 9.86 mmHg in the control group to 
113.00 ± 2.54 mmHg and 105.00 ± 9.35 mmHg in the 20 and 5 ppm of BPA, respectively (p = 0.028, p = 0.007).
The differences between BP reading from PD2 and PD18 is shown in Fig. 3B. The results indicated that SBP 
increased significantly in the 20 ppm (56.4 ± 9.902 mmHg) BPA-exposed pregnant rats in comparison to control 
(10.0 ± 10.775 mmHg) pregnant rats. Meanwhile, DBP also showed the similar pattern in SBP increment of 20 
ppm (21.0 ± 2.534 mmHg) BPA-exposed pregnant rats in comparison to control (17.0 ± 6.979 mmHg) pregnant 
rats.
All mothers significantly gained weight from PD2 to PD18 regardless of whether they were given vehicle con-
trol or being exposed to BPA (Fig. 4A). This suggested that all mothers are healthy throughout the treatment. As 
compared to the control, weight gained of BPA-exposed rats with 5 ppm (54 ± 19.61 g) was found to be significant 
(p = 0.025) and 20 ppm (135 ± 39.95 g) was nearly significant (p = 0.053). Interestingly, the significant difference 
in weight gained was observed between both BPA-exposed groups (p = 0.001). Apart from that, no significant dif-
ferences were observed for the drinking pattern in either control or BPA-exposed rats (Fig. 4B). Although changes 
in the foetuses weight and size were observed, however, there were no significant differences in both parameters 
between control and BPA-exposed foetuses (Fig. 5A,B, respectively).
Figure 1. BPA shows no effect on mothers and foetuses liver histology. Representative of liver section of control 
(A) and BPA-exposed (B) pregnant rat, Foetal liver section at PD21 from pregnant rats of control (C) and BPA-
exposed (D) stained with hematoxylin and eosin dye (10X magnification).
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Bisphenol A prenatal exposure alter foetuses cardiac miRNAs involved in development and diseases. miR-17-5p, 
-21-5p and -133a-3p have been reported to be upregulated during the incidence of cardiac disease. These miR-
NAs are important in cardiomyocytes proliferation and development45. In this study, significant elevation of 
miR-17-5p expression was observed in 5 ppm (1.50 ± 1.14) and 20 ppm (2.25 ± 1.34) compared to the control 
(p = 0.027) (Fig. 6).
In addition, significant upregulation of miR-208a-3p and -210-3p were seen in BPA-treated group compared 
to the control group (Fig. 7). miR-208a-3p has been observed to be upregulated during muscle injury and car-
diac hypertrophy. miR-208a-3p increased only in 20 ppm BPA (4.30 ± 13.19, p = 0.039). A similar finding was 
observed in the expression of miR-210-3p with an upregulation in 20 ppm BPA (2.70 ± 1.25, p = 0.039).
Figure 2. BPA exposure effects mothers and foetal hearts histology. Representative of heart section of control 
(A) and 5ppm and 20ppm BPA-exposed (B,C) pregnant rats, Foetal heart section at PD21 from pregnant 
rats of control (D) and 5 ppm and 20 ppm BPA-exposed (E,F) stained with haematoxylin and eosin dye (40X 
magnification).
Figure 3. BPA exposure effects mothers blood pressure. (A) Diastolic blood pressure (DBP) and systolic 
blood pressure (SBP) reading in control, 5 ppm BPA-exposed and 20 ppm BPA-exposed pregnant rat. (B) Data 
are expressed as means of differences DBP and SBP readings from pregnancy day 2 with pregnancy day 18 
compared to control. Significance differences in SBP was observed in both 5 ppm and 20 ppm BPA exposed 
pregnant rat with control pregnant rat. Meanwhile no significance differences was observed between all groups. 
(n = 5). (*p < 0.05; **p < 0.01; ***p < 0.001).
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In the mother’s heart tissues, only miR-499-5p was significantly elevated in both BPA-exposed groups, 5 ppm 
(1.79 ± 0.60) and 20 ppm (2.25 ± 0.45) (p = 0.005) (Fig. 8). The significant values of miRNA expression are as 
tabulated in Table 2.
Cardiac fibrosis and expression of cardiac troponin I in BPA-exposed foetal heart. In here, non-prominent pres-
ence of fibrosis was observed in heart of pregnant rats of BPA-treated groups compared to control (Fig. 9). As 
for foetus, Masson trichrome staining further confirmed the appearance of fibrosis observed in H&E staining 
(Fig. 10), BPA-exposed foetal heart showed signs of fibrosis (in red circle) based on the observation. However, 
more prominent sign of fibrosis was confirmed in 20 ppm of BPA-exposed foetal heart compared to 5 ppm and 
control. The expression of cardiac troponin I (cTnI) was reduced in BPA-exposed foetal heart compared to the 
control of foetal heart (Fig. 11).
Discussion. Many in vivo and in vitro studies have investigated the detrimental effects of BPA exposure in 
the early development of different organs and cell types. Recently, BPA has been shown to affect the normal 
function of in vitro fetus heart model46. In the liver, abnormalities in its function and damage were reported in rat 
offspring of BPA-exposed pregnant rats47. The study demonstrated that the liver abnormalities and damage were 
only observed at the postnatal of week 21 offspring from BPA-exposed pregnant rats. Meanwhile, in our study, we 
showed that prenatal exposure of 5 ppm and 20 ppm BPA had no significant effects on the liver morphology of the 
foetuses and pregnant rats. The structure of the liver portrays normal hepatic function suggesting that prenatal 
BPA exposure at these doses does not exert hepatotoxicity. Although the doses used in this study are high (5 ppm 
and 20 ppm), these high BPA concentrations have been suggested as estimated daily intake based on data extrap-
olated from urinary BPA levels48. A previous study on reproductive organs observed no increment of cancer in 
0.015-75 ppm and 750–7500 ppm of BPA exposure49. However, other studies documented that BPA foetal expo-
sure at the range of environmental (less than 1 ppm) and high concentration (15 to 150ppm) showed a correlation 
of BPA concentration with its detrimental effects on the embryos 50,51. Similarly, this study demonstrated the effect 
Figure 4. BPA exposure during pregnancy affect weight gained of mothers. (A) Body weight of (wt) and (B) 
drinking pattern of control, 5 ppm BPA-exposed and 20 ppm BPA-exposed pregnant rats. Data are expressed as 
means. (n ≥ 5).*p < 0.05; **p < 0.01.
Figure 5. BPA has no effect on number and weight of foetuses. (A) Number of Foetuses (B) Birth Weight of 
Foetuses (wt). Data are expressed as means. (n > 5 mothers); more than one offspring were selected per litter.
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of BPA in both the mothers and foetus hearts, whereby histology on the heart of the BPA-exposed pregnant rats 
showed injury in the muscle which could be due to the necrotic process or cardiomegaly. Meanwhile, in the foe-
tuses, histology examination showed a sign of fibrosis compared to the control. These suggested that BPA might 
give an impact on foetal development within the chosen concentrations.
Nevertheless, this study revealed a correlation between positive weight gain in the BPA-exposed groups with 
raised SBP readings throughout the treatment (Fig. 3). Increased body weight has been identified as a risk factor 
for hypertension development during pregnancy52. This could be due to the rise in cardiac output and heart rate. 
Recently, researchers have reported the association of CVD with hypertension in the BPA-exposed individual. 
These two chronic diseases are very common as one of the public health problems53. Thus, Han et. al (2016) 
Figure 6. miR-17-5p was upregulated in foetuses heart of BPA-exposed pregnant rats. miRNA expression of 
(A) miR-21-5p (B) miR-15b-3p (C) miR-133a-3p (D) miR-17-5p were measured in the heart of foetuses of 
control and BPA-exposed pregnant rats. All the miRNA have been reported involved in cardiac development. 
Data are expressed as means. (n = 5 rats per group). *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 7. miR-208a-3p and miR-210-3p were upregulated in foetuses heart of BPA-exposed pregnant rat. (A) 
miR-208a-3p (B) miR-30a-5p (C) miR-499-5p (D) miR-210-3p expression were measured in foetuses heart of 
control and BPA-exposed pregnant rats. Altered expression in these miRNAs have been associated with increase 
risk of cardiac disease development. Data are expressed as means. (n = 5 rats per group). *p < 0.05; **p < 0.01; 
***p < 0.001.
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conducted a study to investigate the association between BPA exposure and CVD development of in a rand-
omized clinical trial. The study observed an increment in SBP with 4.5 mmHg after the exposure to BPA. Our 
results were in agreement with those findings where we showed changes in BP in BPA-exposed pregnant rats 
compared to the control pregnant rats. Although the mechanisms of associations between BPA, hypertension and 
CVD were unclear, it could occur due to several factors such as endocrine disruptor, oxidative stress and inflam-
mation induction, links with other chronic diseases and epigenetic changes.
As shown in Fig. 4A, all rats gained weight throughout the treatment period. However, a significant weight 
gain was observed after the exposure of 5 ppm BPA compared to the control pregnant rats (p = 0.025). This 
observation was in line with few reported studies, which demonstrated an increment of weight in those exposed 
with BPA8,54,55. Exposure to an endocrine-disrupting chemical such as BPA promotes adipogenesis and weight 
gain. This made BPA as a potential determinant of obesity56. This study also confirms the obesogenic impacts on 
male mice after BPA exposure. In contrast, another study reported no significant differences in weight between 
vehicle control and BPA groups57. The study was conducted on Sprague-Dawley rats from gestational day 6 until 
postnatal day 90. They observed no significant increment on the gestational length and bodyweight of the pups 
exposed to BPA. This is in line with the results reported in this study (Fig. 5B). They interpreted that certain BPA 
dosage might not affect the endpoint results although few previous studies reported on the effect of BPA exposure 
on weight gain.
Figure 8. BPA exposure has significant effect on miR-499-5p expression of mother’s heart. miR-499-5p is 
related to myocardial infarction. Data are expressed as means. (n = 5 rats per group).
miRNAs
BPA concentration 
(ppm) Mother p-value Foetus p-value
miR-15b-3p




20 0.494 ± 0.284 0.982 ± 0.534
miR-17-5p




20 0.793 ± 0.369 2.257 ± 1.343
miR-21-5p




20 0.609 ± 0.222 1.009 ± 0.189
miR−133a-3p




20 1.817 ± 2.880 1.916 ± 2.974
miR-208a-3p




20 1.932 ± 48.973 4.301 ± 13.191
miR-499-5p




20 2.255 ± 0.448 1.291 ± 0.241
miR-210-3p




20 0.977 ± 0.412 2.698 ± 1.249
miR-30a-5p




20 2.262 ± 3.411 1.683 ± 1.096
Table 2. Expression miRNAs important in heart development and diseases of foetuses heart from BPA-exposed 
pregnant rats. Values presented as mean ± SEM, n = 5. p-values generated from Non parametric Study Kruskal 
Wallis Test. *Indicates treatment significantly different from baseline, p < 0.05.
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Epigenetic modifications are known to be related to diseases such as CVD and there are many studies have 
already linking epigenetic changes with BPA exposure58. Based on these findings, we further investigated the 
impact of BPA exposure on miRNAs. Three out of eight targeted cardiac-related miRNAs exhibited altered 
expression in foetuses of BPA-exposed group. This observation is in agreement with a study that was conducted 
by Barry et. al. (2013) in investigating the toxicity levels of BPA in rats57. Previous study observed overexpression 
of miR-21 in BPA-induced 3T3-L1 cells as it has been reported to be an important gene in the regulation of insulin 
and glucose59. Nevertheless, previous study also reviewed the abnormally expressed miR-21–5p in cancer devel-
opment such as breast, lungs and colorectal60.
miR-133a-3p and -208a-3p are involved in cardiomyocytes proliferation and differentiation45. As we were 
focusing on the possibility of the offspring to develop cardiac disease, miRNAs related to cardiac disease were 
chosen. Interestingly, miR-208a-3p was elevated in foetuses with 20 ppm BPA-exposed pregnant rat (p = 0.039). 
miR-208a-3p is involved in cardiac contractility and function, where the expression of this gene in response 
to modulation of myosin heavy chain results in the upregulation of βMHC. miR-208a-3p is a cardiac-specific 
Figure 9. BPA exposure effects mothers hearts Masson Trichrome staining. Representative of heart section 
of control (A) and 5ppm and 20ppm BPA-exposed (B,C) pregnant rats, stained with Masson trichrome (10X 
magnification). (D–F represents section in 40X magnification).
Figure 10. BPA exposure effects foetal hearts Masson Trichrome staining. Representative of heart section of 
control (A) and 5ppm and 20ppm BPA-exposed (B,C) of foetal heart (10X magnification). (D–F) Foetal heart 
section at PD21 from pregnant rats of control, 5 ppm BPA and 20 ppm BPA-exposed (40X magnification). Note: 
BV = Blood vessel. The red circle represents sign of fibrosis with bluish stained.
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miRNA and has been reported to be an important miRNA in cardiomyocyte hypertrophy and fibrosis3. This gene 
is absent in healthy subject thus, the elevation of its expression suggested a modification in the heart of the foetus 
exposed to BPA.
This study also focuses on the impact of BPA exposure on the heart of mothers and foetuses, by H&E, Masson 
trichrome (MT) staining, cTnI expression and cardiac miRNA profile. Our findings showed that elevated expres-
sion of miR-208-3p (in foetal heart) and miR-499-5p (in mothers heart) after exposure to BPA could be asso-
ciated with the expression of cardiac troponin I (cTnI) (Fig. 11). This findings are in agreement with previous 
reported studies which associated the upregulation of miR-208a and miR-499 with cTnI expression7,61,62.
In agreement with our findings, miR-17-5p is elevated in foetus-exposed to BPA, thus, suggested the possibil-
ity of the offspring to develop heart disease later in life. There was study documented on a role of miR-17 in liver 
and cardiac fibrosis63. miR-210-3p is significantly expressed in the BPA-exposed foetus heart, which suggests that 
Figure 11. BPA exposure effects foetal cardiac troponin I (cTnI) expression. Immunofluorescence staining of 
foetal heart section subjected to cardiac troponin I expression. (A) control foetal heart, (B) 0.05 mg/ml BPA-
exposed, (C) 0.2 mg/ml BPA-exposed foetal heart, stained with DAPI and FITC. ZF 2.6 (n = 8). Scale bar 25 µm 
and 75 µm.
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this miRNA has an impact on angiogenesis and fibrosis64. In parallel, a study reported similarities between foetal 
and failing heart in which elevated miR-210-3p was observed, indicating the prevalence of heart failure devel-
opment65. In our findings, this gene is significantly altered in 20 ppm of BPA-exposed foetus heart. Moreover, 
our H&E and MT staining indicated fibrosis in both BPA exposed groups compared to control group. However, 
the fibrosis was more prominent in 20 ppm BPA. Previously, BPA shown to upregulate the expression of marker 
for fibrosis such as interleukin-6 (IL-6) and collagen type 166,67. In here, our result is the first to suggest that BPA 
exposure during prenatal life may altered cardiac miRNAs and induced fibrosis.
conclusions. There is increasing evidence that exposure to BPA during the intrauterine environment may 
play a significant role in the global health problems specifically in the development of CVD. BPA has the poten-
tial to induce obesity and hypertension in the exposed individual during pregnancy. As the foetus is partially 
protected from the adverse effect of environmental conditions, in utero exposures of BPA may give impact to the 
foetus indirectly. Furthermore, our data suggest that altered miRNA expression in the foetus do affect the heart 
tissues. Thus further study need to be done on understanding whether these changes seen in BPA-exposed foetus 
could increase the risk of CVD in offspring later in life.
Limitation
There are some limitations to this study. Firstly, this study focused on the impact of miRNAs expression in the 
foetal hearts only and does not extend until in postnatal life. However, the expression during postnatal life could 
be influenced by other factors such as environmental and nutrient intake that could interfere with the overall 
findings. Secondly, the number of the sample size used in this study is limited to 5. The expression could be more 
significant if the sample size is bigger than 5.
ethics approval. This study was conducted in accordance of relevance guidelines and regulations, and 
approved by Universiti Teknologi MARA (UiTM) Committee of Animal Research and Ethics (Approval Number 
UiTM CARE: 222/7/2017 (8/12/2017)).
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The datasets used and/or analysed in this study are available from the corresponding author on reasonable 
request.
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